SCHEMBL2961402

SCHEMBL2961402

Cc1ccc2c(c1)-c1cc(C)ccc1[N]2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.41
CYP2A6 P11509 3/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
ELANE P08246 1/20 0.39
TDP1 Q9NUW8 5/20 0.37
ACHE P22303 2/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
TRPA1 O75762 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962416 0.89 ELANE (0.47) CYP2A6MAOAMAOBELANETDP1
SCHEMBL20553777 0.80 MEN1 (0.38) TDP1ACHESMN1; SMN2
SCHEMBL23537533 0.78 CYP1A2 (0.41) CYP1A2CYP2A6MAOAMAOBELANE
SCHEMBL22038216 0.74 ALDH1A1 (0.44) CYP1A2CYP2A6MAOAMAOBELANE
SCHEMBL3871108 0.74 ELANE (0.47) CYP2A6MAOAMAOBELANETDP1
SCHEMBL3876013 0.73 MEN1 (0.40) TDP1SMN1; SMN2HTTTP53THRB
SCHEMBL28662585 0.72 MAOA (0.42) CYP1A2CYP2A6MAOAMAOBELANE
SCHEMBL20553967 0.70 ENPP3 (0.44) SMN1; SMN2TP53THRBALDH1A1
SCHEMBL1134706 0.69 MAOA (0.55) CYP1A2CYP2A6MAOAMAOBELANE
SCHEMBL1134729 0.69 MAOA (0.55) CYP1A2CYP2A6MAOAMAOBELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10144791-B2 Molecular weight control of polyolefins using halogenated bis-phenylphenoxy catalysts DOW GLOBAL TECHNOLOGIES LLC (US) 2018-12-04 US claimed
CN-118251380-A Spiro- (indan-fluorene) compounds and their use in organic electronic devices 多蒂肯独家合成控股公司 2024-06-25 CN disclosed
US-20240188436-A1 COMPOSITION, USE OF SAID COMPOSITION AS LIGHT-EMITTING COMPOSITION, FILM, USE OF SAID FILM AS LIGHT-EMITTING FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR DESIGNING COMPOSITION, AND PROGRAM FOR IMPLEMENTING SAID DESIGN METHOD KYULUX, INC. (JP) 2024-06-06 US disclosed
US-20240150502-A1 BIPHENYLPHENOL POLYMERIZATION CATALYSTS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-05-09 US disclosed
US-11937495-B2 Organic light emitting element, composition and membrane KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2024-03-19 US disclosed
CN-117561263-A Compound, electron blocking material, organic semiconductor element, and compound 九州有机光材股份有限公司 2024-02-13 CN disclosed
EP-4310930-A1 COMPOSITION, USE OF SAID COMPOSITION AS LIGHT-EMITTING COMPOSITION, FILM, USE OF SAID FILM AS LIGHT-EMITTING FILM, ORGANIC ELECTROLUMINESCNET ELEMENT, METHOD FOR DESIGNING COMPOSITION, AND PROGRAM FOR IMPLEMENTING SAID DESIGN METHOD Kyulux, Inc. (JP) 2024-01-24 EP disclosed
EP-4291585-A1 BIPHENYLPHENOL POLYMERIZATION CATALYSTS Dow Global Technologies LLC (US) 2023-12-20 EP disclosed
CN-117121651-A Composition, use of the composition as light-emitting composition, film, use of the film as light-emitting film, organic electroluminescent element, method for designing composition, and program for implementing the method 九州有机光材股份有限公司 2023-11-24 CN disclosed
EP-3843168-B1 ORGANIC LIGHT EMITTING ELEMENT, COMPOSITION AND MEMBRANE UNIV KYUSHU NAT UNIV CORP (JP) 2023-10-11 EP disclosed
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same JNC CORPORATION (JP) 2010-02-04 US disclosed
CN-100555706-C The organic luminescent device that contains the triazine electron transport layer of doping LG PHILIPS LCD CO LTD (KR) 2009-10-28 CN disclosed
US-7482490-B2 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound TOSOH CORPORATION (JP) 2009-01-27 US disclosed
US-20080194878-A1 Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound TOSOH CORPORATION (JP) 2008-08-14 US disclosed
US-7189877-B2 Arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices TOSCH CORPORATION (JP) 2007-03-13 US disclosed
EP-1752440-A1 AMINE COMPOUND HAVING FLUORENE GROUP AS FRAMEWORK, PROCESS FOR PRODUCING THE AMINE COMPOUND, AND USE OF THE AMINE COMPOUND Tosoh Corporation (JP) 2007-02-14 EP disclosed
CN-1858925-A Organic light emitting devices comprising a doped triazine electron transport layer LG PHILIPS LCD CO LTD (KR) 2006-11-08 CN disclosed
EP-1400578-B1 Electrolumisescent 9,9-bis(4-amino)-1,1'-biphenyl)fluorene derivatives TOSOH CORP (JP) 2005-11-30 EP disclosed
US-20040110958-A1 Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices TOSOH CORPORATION 2004-06-10 US disclosed
EP-1400578-A1 Electrolumisescent 9,9-bis(4-amino)-1,1'-biphenyl)fluorene derivatives Tosoh Corporation (JP) 2004-03-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11937495-B2 Organic light emitting element, composition and membrane CRY1, INTS9, CYBA CYP1A2 481/4885CYP2A6 1473/4885MAOA 3667/4885
US-20040110958-A1 Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices AHR, NAT1, AR CYP1A2 22/4885CYP2A6 257/4885MAOA 75/4885
US-20080194878-A1 Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound TAAR1, SLC18A1, ADRB2 CYP1A2 312/4885CYP2A6 1015/4885MAOA 104/4885
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same TRPV3, TRPC3, HVCN1 CYP1A2 1391/4885CYP2A6 2970/4885MAOA 2468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.